ONC-4

N/A

Report date: 2025/06/11 11:23:29
NME

Base Information

Drug NameONC-4
Drug Alias NameCYRS-ONC04ONC-4C-09045
ClassificationSmall molecules
Mechanisms of ActionAnticancer protein kinase inhibitorsEpidermal growth factor receptor erbB1 modulatorsApoptosis stimulants
TargetsEpidermal growth factor receptor erbB1
Therapy Area/IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCyrus Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCyrus Therapeutics IncBridge Biotherapeutics Inc
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell Lung
Inactive IndicationsSolid tumoursNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A